318 related articles for article (PubMed ID: 8590733)
1. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
Harms JS; Splitter GA
Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
[TBL] [Abstract][Full Text] [Related]
2. Regulation of transgene expression in genetic immunization.
Harms JS; Oliveira SC; Splitter GA
Braz J Med Biol Res; 1999 Feb; 32(2):155-62. PubMed ID: 10347750
[TBL] [Abstract][Full Text] [Related]
3. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.
Qin L; Ding Y; Pahud DR; Chang E; Imperiale MJ; Bromberg JS
Hum Gene Ther; 1997 Nov; 8(17):2019-29. PubMed ID: 9414251
[TBL] [Abstract][Full Text] [Related]
4. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
[TBL] [Abstract][Full Text] [Related]
5. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
6. Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter.
Duan B; Cheng L; Gao Y; Yin FX; Su GH; Shen QY; Liu K; Hu X; Liu X; Li GP
Theriogenology; 2012 Sep; 78(4):793-802. PubMed ID: 22541322
[TBL] [Abstract][Full Text] [Related]
7. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
8. Comparison of CMV, RSV, SV40 viral and Vlambda1 cellular promoters in B and T lymphoid and non-lymphoid cell lines.
Zarrin AA; Malkin L; Fong I; Luk KD; Ghose A; Berinstein NL
Biochim Biophys Acta; 1999 Jul; 1446(1-2):135-9. PubMed ID: 10395926
[TBL] [Abstract][Full Text] [Related]
9. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
[TBL] [Abstract][Full Text] [Related]
10. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
12. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
15. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
17. Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc.
Xu ZZ; Krougliak V; Prevec L; Graham FL; Both GW
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1971-80. PubMed ID: 7636477
[TBL] [Abstract][Full Text] [Related]
18. High levels of protein expression using different mammalian CMV promoters in several cell lines.
Xia W; Bringmann P; McClary J; Jones PP; Manzana W; Zhu Y; Wang S; Liu Y; Harvey S; Madlansacay MR; McLean K; Rosser MP; MacRobbie J; Olsen CL; Cobb RR
Protein Expr Purif; 2006 Jan; 45(1):115-24. PubMed ID: 16289982
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Different Promoters and
Li Q; Wang XY; Zhao CP; Tian ZW; Xu DH; Wang TY; Zhang JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):18-23. PubMed ID: 29737083
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of TTR and CMV promoters in vivo and in vitro via a secreted luciferase reporter system].
Luo ST; Tian WH; Wang G; Dong XY; Yang L; Wu XB
Bing Du Xue Bao; 2009 Nov; 25(6):424-9. PubMed ID: 20077932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
